| rec. | Subject | Hit Length | Description | Align.Len | E value | Bit score | % ident. | % pos. | GO associations |
511 | Q5UPG0 | 576 | YL086_MIMIV Putative ankyrin repeat protein L... | 252 | 0.069 | 40.8 | 24 | 44 | | | | | | | | | | | | | | | | | | | | | | 512 | Q1RI12 | 694 | Y921_RICBR Putative ankyrin repeat protein RB... | 34 | 1.7 | 36.6 | 53 | 68 | | | | | | | | | | | | | | | | | | | | | | 513 | Q4P6L3 | 844 | AKR1_USTMA Palmitoyltransferase AKR1 OS=Ustil... | 148 | 0.003 | 45.4 | 28 | 43 | GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.::GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.::GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW.::GO:0008270; F:zinc ion binding; IEA:InterPro. | | | | | | | | | | | 514 | Q91974 | 318 | IKBA_CHICK NF-kappa-B inhibitor alpha OS=Gall... | 112 | 0.00009 | 49.7 | 33 | 47 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | | | | | | | | | | | GO:0035419; P:activation of MAPK activity involved in innate immune response; TAS:Reactome.::GO:0007250; P:activation of NF-kappaB-inducing kinase activity; TAS:Reactome.::GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.::GO:0048145; P:regulation of fibroblast proliferation; NAS:UniProtKB.::GO:0035681; P:toll-like receptor 15 signaling pathway; TAS:Reactome.::GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome.::GO:0035682; P:toll-like receptor 21 signaling pathway; TAS:Reactome.::GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome.::GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome.::GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome.::GO:0034154; P:toll-like receptor 7 signaling pathway; TAS:Reactome. | 515 | Q8BLD6 | 626 | ANR55_MOUSE Ankyrin repeat domain-containing ... | 116 | 0.054 | 41.2 | 30 | 42 | | | | | | | | | | | | | | | | | | | | | | 516 | Q875S9 | 737 | AKR1_LACKL Palmitoyltransferase AKR1 OS=Lacha... | 58 | 0.022 | 42.7 | 41 | 52 | GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.::GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.::GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW.::GO:0008270; F:zinc ion binding; IEA:InterPro. | | | | | | | | | | | 517 | Q4R690 | 622 | ZDH13_MACFA Palmitoyltransferase ZDHHC13 OS=M... | 53 | 0.006 | 44.3 | 36 | 60 | GO:0030660; C:Golgi-associated vesicle membrane; ISS:UniProtKB.::GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | GO:0015095; F:magnesium ion transmembrane transporter activity; ISS:UniProtKB.::GO:0016409; F:palmitoyltransferase activity; ISS:UniProtKB.::GO:0008270; F:zinc ion binding; IEA:InterPro. | | | | | | | | | | | 518 | Q811D2 | 1581 | ANR26_MOUSE Ankyrin repeat domain-containing ... | 149 | 0.004 | 45.4 | 27 | 48 | | | | | | | | | | | | | | | | | | | | | | 519 | Q9TXQ1 | 2276 | PME5_CAEEL Poly(ADP-ribose) polymerase pme-5 ... | 67 | 4.7 | 35.4 | 36 | 48 | GO:0005634; C:nucleus; IDA:WormBase. | | | | | | | | | | GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:EC. | | | | | | | | | | GO:0006281; P:DNA repair; IEA:UniProtKB-KW.::GO:0043069; P:negative regulation of programmed cell death; IMP:WormBase.::GO:0006471; P:protein ADP-ribosylation; IEA:InterPro.::GO:0010332; P:response to gamma radiation; IEP:WormBase. | 520 | O14593 | 260 | RFXK_HUMAN DNA-binding protein RFXANK OS=Homo... | 133 | 0.002 | 45.4 | 26 | 48 | GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0003677; F:DNA binding; TAS:ProtInc.::GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc.::GO:0003712; F:transcription cofactor activity; TAS:ProtInc. | | | | | | | | | | GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW. | 521 | Q5UPV1 | 728 | YL271_MIMIV Putative ankyrin repeat protein L... | 68 | 0.9 | 37.4 | 29 | 51 | | | | | | | | | | | | | | | | | | | | | GO:0006520; P:cellular amino acid metabolic process; IEA:InterPro. | 522 | Q6TNT2 | 228 | ANR46_DANRE Ankyrin repeat domain-containing ... | 114 | 0.037 | 40.8 | 27 | 50 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | | | | | | | | | | | | 523 | Q5UP12 | 147 | YR847_MIMIV Putative ankyrin repeat protein R... | 105 | 0.001 | 43.9 | 31 | 50 | | | | | | | | | | | | | | | | | | | | | | 524 | Q9H560 | 264 | ANR19_HUMAN Putative ankyrin repeat domain-co... | 192 | 0.00000009 | 58.5 | 29 | 47 | | | | | | | | | | | | | | | | | | | | | | 525 | Q01317 | 1066 | NUC2_NEUCR Ankyrin repeat protein nuc-2 OS=12... | 170 | 0.28 | 39.3 | 24 | 44 | | | | | | | | | | | GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.::GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:InterPro. | | | | | | | | | | GO:0006071; P:glycerol metabolic process; IEA:InterPro.::GO:0006629; P:lipid metabolic process; IEA:InterPro.::GO:0006508; P:proteolysis; IEA:InterPro. | 526 | A0JNU3 | 564 | LPP60_MOUSE 60 kDa lysophospholipase OS=Mus m... | 119 | 0.006 | 44.3 | 28 | 48 | | | | | | | | | | | GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:EC.::GO:0004067; F:asparaginase activity; IEA:EC.::GO:0004622; F:lysophospholipase activity; IEA:EC. | | | | | | | | | | GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW. | 527 | Q5URB8 | 601 | YR841_MIMIV Putative ankyrin repeat protein R... | 265 | 0.0005 | 47.8 | 25 | 42 | | | | | | | | | | | | | | | | | | | | | | 528 | Q1RJN6 | 334 | Y347_RICBR Putative ankyrin repeat protein RB... | 182 | 0.0003 | 47.8 | 29 | 41 | | | | | | | | | | | | | | | | | | | | | | 529 | Q63ZY3 | 851 | KANK2_HUMAN KN motif and ankyrin repeat domai... | 176 | 0.0002 | 48.9 | 27 | 49 | | | | | | | | | | | | | | | | | | | | | | 530 | Q86U10 | 573 | LPP60_HUMAN 60 kDa lysophospholipase OS=Homo ... | 93 | 0.81 | 37.4 | 30 | 44 | | | | | | | | | | | GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:EC.::GO:0004067; F:asparaginase activity; IEA:EC.::GO:0004622; F:lysophospholipase activity; IEA:EC. | | | | | | | | | | GO:0006520; P:cellular amino acid metabolic process; IEA:InterPro.::GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW. | 531 | Q8N2N9 | 1353 | AN36B_HUMAN Ankyrin repeat domain-containing ... | 125 | 0.002 | 46.2 | 28 | 47 | | | | | | | | | | | | | | | | | | | | | | 532 | P07207 | 2703 | NOTCH_DROME Neurogenic locus Notch protein OS... | 163 | 0.13 | 40.4 | 25 | 46 | GO:0005912; C:adherens junction; IDA:FlyBase.::GO:0005829; C:cytosol; TAS:Reactome.::GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.::GO:0005796; C:Golgi lumen; TAS:Reactome.::GO:0016021; C:integral to membrane; TAS:FlyBase.::GO:0005654; C:nucleoplasm; TAS:Reactome.::GO:0043234; C:protein complex; IPI:FlyBase.::GO:0035003; C:subapical complex; IDA:FlyBase. | | | | | | | | | | GO:0005509; F:calcium ion binding; IEA:InterPro.::GO:0003682; F:chromatin binding; IDA:FlyBase.::GO:0005515; F:protein binding; IPI:UniProtKB.::GO:0004888; F:transmembrane signaling receptor activity; NAS:FlyBase. | | | | | | | | | | GO:0007015; P:actin filament organization; IMP:FlyBase.::GO:0008356; P:asymmetric cell division; TAS:FlyBase.::GO:0007298; P:border follicle cell migration; IMP:FlyBase.::GO:0008407; P:chaeta morphogenesis; IMP:FlyBase.::GO:0042676; P:compound eye cone cell fate commitment; TAS:FlyBase.::GO:0046667; P:compound eye retinal cell programmed cell death; TAS:FlyBase.::GO:0046843; P:dorsal appendage formation; IMP:FlyBase.::GO:0007391; P:dorsal closure; TAS:FlyBase.::GO:0007451; P:dorsal/ventral lineage restriction, imaginal disc; TAS:FlyBase.::GO:0007398; P:ectoderm development; TAS:FlyBase.::GO:0035165; P:embryonic crystal cell differentiation; TAS:FlyBase.::GO:0061331; P:epithelial cell proliferation involved in Malpighian tubule morphogenesis; IMP:FlyBase.::GO:0035153; P:epithelial cell type specification, open tracheal system; IMP:FlyBase.::GO:0035214; P:eye-antennal disc development; IMP:FlyBase.::GO:0007440; P:foregut morphogenesis; IMP:FlyBase.::GO:0030718; P:germ-line stem cell maintenance; IMP:FlyBase.::GO:0030708; P:germarium-derived female germ-line cyst encapsulation; TAS:FlyBase.::GO:0007403; P:glial cell fate determination; IMP:FlyBase.::GO:0008347; P:glial cell migration; IMP:FlyBase.::GO:0035172; P:hemocyte proliferation; IMP:FlyBase.::GO:0007157; P:heterophilic cell-cell adhesion; IMP:FlyBase.::GO:0007446; P:imaginal disc growth; TAS:FlyBase.::GO:0036011; P:imaginal disc-derived leg segmentation; IMP:FlyBase.::GO:0048803; P:imaginal disc-derived male genitalia morphogenesis; IMP:FlyBase.::GO:0008587; P:imaginal disc-derived wing margin morphogenesis; IMP:FlyBase.::GO:0007474; P:imaginal disc-derived wing vein specification; IMP:FlyBase.::GO:0035171; P:lamellocyte differentiation; IMP:FlyBase.::GO:0046331; P:lateral inhibition; NAS:FlyBase.::GO:0007616; P:long-term memory; IMP:FlyBase.::GO:0035170; P:lymph gland crystal cell differentiation; TAS:FlyBase.::GO:0061382; P:Malpighian tubule tip cell differentiation; IMP:FlyBase.::GO:0007498; P:mesoderm development; IMP:FlyBase.::GO:0008045; P:motor axon guidance; IMP:FlyBase.::GO:0007521; P:muscle cell fate determination; IMP:FlyBase.::GO:0045316; P:negative regulation of compound eye photoreceptor development; IMP:FlyBase.::GO:0035157; P:negative regulation of fusion cell fate specification; TAS:FlyBase.::GO:0046329; P:negative regulation of JNK cascade; NAS:FlyBase.::GO:0050768; P:negative regulation of neurogenesis; IMP:FlyBase.::GO:0035155; P:negative regulation of terminal cell fate specification, open tracheal system; TAS:FlyBase.::GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:FlyBase.::GO:0007400; P:neuroblast fate determination; IDA:FlyBase.::GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.::GO:0007314; P:oocyte anterior/posterior axis specification; TAS:FlyBase.::GO:0030720; P:oocyte localization involved in germarium-derived egg chamber formation; IMP:FlyBase.::GO:0030713; P:ovarian follicle cell stalk formation; IMP:FlyBase.::GO:0007422; P:peripheral nervous system development; IMP:FlyBase.::GO:0008284; P:positive regulation of cell proliferation; IMP:FlyBase.::GO:0045747; P:positive regulation of Notch signaling pathway; IMP:FlyBase.::GO:0045750; P:positive regulation of S phase of mitotic cell cycle; IMP:FlyBase.::GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:FlyBase.::GO:0048052; P:R1/R6 cell differentiation; IMP:FlyBase.::GO:0007464; P:R3/R4 cell fate commitment; NAS:FlyBase.::GO:0045466; P:R7 cell differentiation; IMP:FlyBase.::GO:0045463; P:R8 cell development; TAS:FlyBase.::GO:0007460; P:R8 cell fate commitment; TAS:FlyBase.::GO:0042686; P:regulation of cardioblast cell fate specification; IMP:FlyBase.::GO:0042689; P:regulation of crystal cell differentiation; TAS:FlyBase.::GO:0051489; P:regulation of filopodium assembly; IMP:FlyBase.::GO:0040008; P:regulation of growth; IMP:FlyBase.::GO:0045468; P:regulation of R8 cell spacing in compound eye; NAS:FlyBase.::GO:0009608; P:response to symbiont; IMP:FlyBase.::GO:0016330; P:second mitotic wave involved in compound eye morphogenesis; NAS:FlyBase.::GO:0007519; P:skeletal muscle tissue development; IMP:FlyBase.::GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.::GO:0007419; P:ventral cord development; NAS:FlyBase.::GO:0048190; P:wing disc dorsal/ventral pattern formation; IMP:FlyBase.::GO:0007473; P:wing disc proximal/distal pattern formation; TAS:FlyBase. | 533 | P67656 | 255 | MTNN_MYCTU MTA/SAH nucleosidase OS=Mycobacter... | 290 | 0.00000008 | 58.5 | 25 | 42 | | | | | | | | | | | GO:0008782; F:adenosylhomocysteine nucleosidase activity; IEA:EC.::GO:0008930; F:methylthioadenosine nucleosidase activity; IEA:InterPro. | | | | | | | | | | GO:0019509; P:L-methionine salvage from methylthioadenosine; IEA:InterPro.::GO:0009164; P:nucleoside catabolic process; IEA:InterPro. | 534 | P67657 | 255 | MTNN_MYCBO MTA/SAH nucleosidase OS=Mycobacter... | 290 | 0.00000008 | 58.5 | 25 | 42 | | | | | | | | | | | GO:0008782; F:adenosylhomocysteine nucleosidase activity; IEA:EC.::GO:0008930; F:methylthioadenosine nucleosidase activity; IEA:InterPro. | | | | | | | | | | GO:0019509; P:L-methionine salvage from methylthioadenosine; IEA:InterPro.::GO:0009164; P:nucleoside catabolic process; IEA:InterPro. | 535 | Q14678 | 1352 | KANK1_HUMAN KN motif and ankyrin repeat domai... | 82 | 0.00007 | 51.2 | 35 | 62 | GO:0005737; C:cytoplasm; IDA:HPA. | | | | | | | | | | | | | | | | | | | | GO:0030837; P:negative regulation of actin filament polymerization; IDA:MGI. | 536 | P46531 | 2555 | NOTC1_HUMAN Neurogenic locus notch homolog pr... | 126 | 0.068 | 41.2 | 29 | 51 | GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.::GO:0000139; C:Golgi membrane; TAS:Reactome.::GO:0016021; C:integral to membrane; NAS:UniProtKB.::GO:0002193; C:MAML1-RBP-Jkappa- ICN1 complex; IDA:UniProtKB.::GO:0005654; C:nucleoplasm; TAS:Reactome.::GO:0005886; C:plasma membrane; TAS:Reactome. | | | | | | | | | | GO:0005509; F:calcium ion binding; IEA:InterPro.::GO:0001047; F:core promoter binding; ISS:UniProtKB.::GO:0019899; F:enzyme binding; ISS:UniProtKB.::GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB.::GO:0004872; F:receptor activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0003180; P:aortic valve morphogenesis; IMP:BHF-UCL.::GO:2000811; P:negative regulation of anoikis; IMP:BHF-UCL.::GO:0030514; P:negative regulation of BMP signaling pathway; ISS:BHF-UCL.::GO:0010812; P:negative regulation of cell-substrate adhesion; IDA:BHF-UCL.::GO:0060253; P:negative regulation of glial cell proliferation; ISS:UniProtKB.::GO:0045662; P:negative regulation of myoblast differentiation; IMP:UniProtKB.::GO:0010832; P:negative regulation of myotube differentiation; ISS:UniProtKB.::GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:UniProtKB.::GO:0045668; P:negative regulation of osteoblast differentiation; ISS:BHF-UCL.::GO:2000974; P:negative regulation of pro-B cell differentiation; ISS:UniProtKB.::GO:2000737; P:negative regulation of stem cell differentiation; IMP:UniProtKB.::GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.::GO:0097150; P:neuronal stem cell maintenance; IEP:UniProtKB.::GO:0007220; P:Notch receptor processing; TAS:Reactome.::GO:0048711; P:positive regulation of astrocyte differentiation; ISS:UniProtKB.::GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB.::GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL.::GO:0046427; P:positive regulation of JAK-STAT cascade; ISS:UniProtKB.::GO:0061419; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; ISS:UniProtKB.::GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome. | 537 | Q08353 | 314 | IKBA_PIG NF-kappa-B inhibitor alpha OS=Sus sc... | 168 | 0.000007 | 53.1 | 31 | 48 | GO:0005634; C:nucleus; ISS:AgBase. | | | | | | | | | | GO:0051059; F:NF-kappaB binding; ISS:AgBase.::GO:0008139; F:nuclear localization sequence binding; ISS:AgBase.::GO:0031625; F:ubiquitin protein ligase binding; ISS:AgBase. | | | | | | | | | | GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISS:AgBase.::GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:AgBase.::GO:0045746; P:negative regulation of Notch signaling pathway; ISS:AgBase.::GO:0000060; P:protein import into nucleus, translocation; ISS:AgBase.::GO:0042127; P:regulation of cell proliferation; ISS:AgBase.::GO:0043330; P:response to exogenous dsRNA; ISS:AgBase. | 538 | Q8CGB3 | 1411 | UACA_MOUSE Uveal autoantigen with coiled-coil... | 183 | 0.000002 | 56.2 | 28 | 44 | GO:0043293; C:apoptosome; IDA:MGI.::GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.::GO:0005624; C:membrane fraction; IDA:MGI.::GO:0005635; C:nuclear envelope; IDA:MGI.::GO:0048471; C:perinuclear region of cytoplasm; IDA:MGI.::GO:0005625; C:soluble fraction; IDA:MGI. | | | | | | | | | | GO:0005515; F:protein binding; IPI:MGI. | | | | | | | | | | GO:0008630; P:DNA damage response, signal transduction resulting in induction of apoptosis; IMP:MGI.::GO:0008631; P:induction of apoptosis by oxidative stress; IMP:MGI.::GO:0050728; P:negative regulation of inflammatory response; IMP:MGI.::GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IMP:MGI.::GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:MGI.::GO:0042307; P:positive regulation of protein import into nucleus; IMP:MGI.::GO:0009411; P:response to UV; IMP:MGI. | 539 | Q5UQI8 | 626 | YR837_MIMIV Putative ankyrin repeat protein R... | 258 | 0.27 | 38.9 | 21 | 38 | | | | | | | | | | | | | | | | | | | | | | 540 | Q5ZLC6 | 414 | ANR10_CHICK Ankyrin repeat domain-containing ... | 201 | 0.0004 | 47.8 | 25 | 39 | | | | | | | | | | | | | | | | | | | | | | 541 | P25963 | 317 | IKBA_HUMAN NF-kappa-B inhibitor alpha OS=Homo... | 172 | 0.00005 | 50.4 | 30 | 45 | GO:0005829; C:cytosol; TAS:Reactome.::GO:0033256; C:I-kappaB/NF-kappaB complex; TAS:BHF-UCL.::GO:0005634; C:nucleus; IDA:UniProtKB.::GO:0005886; C:plasma membrane; IDA:HPA. | | | | | | | | | | GO:0042802; F:identical protein binding; IPI:IntAct.::GO:0051059; F:NF-kappaB binding; IPI:UniProtKB.::GO:0008139; F:nuclear localization sequence binding; IPI:UniProtKB.::GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB. | | | | | | | | | | GO:0006916; P:anti-apoptosis; TAS:Reactome.::GO:0006915; P:apoptotic process; TAS:ProtInc.::GO:0070417; P:cellular response to cold; NAS:BHF-UCL.::GO:0007253; P:cytoplasmic sequestering of NF-kappaB; IMP:BHF-UCL.::GO:0045087; P:innate immune response; TAS:Reactome.::GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.::GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.::GO:0043392; P:negative regulation of DNA binding; NAS:UniProtKB.::GO:0010888; P:negative regulation of lipid storage; IMP:BHF-UCL.::GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL.::GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:MGI.::GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome.::GO:0032270; P:positive regulation of cellular protein metabolic process; IMP:BHF-UCL.::GO:0010875; P:positive regulation of cholesterol efflux; IMP:BHF-UCL.::GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome.::GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.::GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.::GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.::GO:0008063; P:Toll signaling pathway; TAS:Reactome.::GO:0034130; P:toll-like receptor 1 signaling pathway; TAS:Reactome.::GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome.::GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome.::GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome.::GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome. |
